Cargando…
Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer
BACKGROUND: We reported previously that rectal cancer patients given curative-intent chemotherapy, radiation, and surgery for non-metastatic disease had enhanced risk of metastatic progression and death if circulating levels of 25-hydroxyvitamin D [25(OH) D] were low. Here we investigated whether th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111928/ https://www.ncbi.nlm.nih.gov/pubmed/33975557 http://dx.doi.org/10.1186/s12885-021-08260-2 |
_version_ | 1783690593299333120 |
---|---|
author | Abrahamsson, Hanna Meltzer, Sebastian Hagen, Vidar Nyløkken Johansen, Christin Bousquet, Paula A. Redalen, Kathrine Røe Ree, Anne Hansen |
author_facet | Abrahamsson, Hanna Meltzer, Sebastian Hagen, Vidar Nyløkken Johansen, Christin Bousquet, Paula A. Redalen, Kathrine Røe Ree, Anne Hansen |
author_sort | Abrahamsson, Hanna |
collection | PubMed |
description | BACKGROUND: We reported previously that rectal cancer patients given curative-intent chemotherapy, radiation, and surgery for non-metastatic disease had enhanced risk of metastatic progression and death if circulating levels of 25-hydroxyvitamin D [25(OH) D] were low. Here we investigated whether the association between the vitamin D status and prognosis pertains to the general, unselected population of rectal cancer patients. METHODS: Serum 25(OH) D at the time of diagnosis was assessed in 129 patients, enrolled 2013–2017 and representing the entire range of rectal cancer stages, and analyzed with respect to season, sex, systemic inflammation, and survival. RESULTS: In the population-based cohort residing at latitude 60°N, 25(OH) D varied according to season in men only, who were overrepresented among the vitamin D-deficient (< 50 nmol/L) patients. Consistent with our previous findings, the individuals presenting with T4 disease had significantly reduced 25(OH) D levels. Low vitamin D was associated with systemic inflammation, albeit with distinct modes of presentation. While men with low vitamin D showed circulating markers typical for the systemic inflammatory response (e.g., elevated erythrocyte sedimentation rate), the corresponding female patients had elevated serum levels of interleukin-6 and the chemokine (C-X-C motif) ligand 7. Despite disparities in vitamin D status and the potential effects on disease attributes, significantly shortened cancer-specific survival was observed in vitamin D-deficient patients irrespective of sex. CONCLUSION: This unselected rectal cancer cohort confirmed the interconnection of low vitamin D, more advanced disease presentation, and poor survival, and further suggested it may be conditional on disparate modes of adverse systemic inflammation in men and women. TRIAL REGISTRATION: ClinicalTrials.govNCT01816607; registration date: 22 March 2013. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08260-2. |
format | Online Article Text |
id | pubmed-8111928 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81119282021-05-11 Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer Abrahamsson, Hanna Meltzer, Sebastian Hagen, Vidar Nyløkken Johansen, Christin Bousquet, Paula A. Redalen, Kathrine Røe Ree, Anne Hansen BMC Cancer Research Article BACKGROUND: We reported previously that rectal cancer patients given curative-intent chemotherapy, radiation, and surgery for non-metastatic disease had enhanced risk of metastatic progression and death if circulating levels of 25-hydroxyvitamin D [25(OH) D] were low. Here we investigated whether the association between the vitamin D status and prognosis pertains to the general, unselected population of rectal cancer patients. METHODS: Serum 25(OH) D at the time of diagnosis was assessed in 129 patients, enrolled 2013–2017 and representing the entire range of rectal cancer stages, and analyzed with respect to season, sex, systemic inflammation, and survival. RESULTS: In the population-based cohort residing at latitude 60°N, 25(OH) D varied according to season in men only, who were overrepresented among the vitamin D-deficient (< 50 nmol/L) patients. Consistent with our previous findings, the individuals presenting with T4 disease had significantly reduced 25(OH) D levels. Low vitamin D was associated with systemic inflammation, albeit with distinct modes of presentation. While men with low vitamin D showed circulating markers typical for the systemic inflammatory response (e.g., elevated erythrocyte sedimentation rate), the corresponding female patients had elevated serum levels of interleukin-6 and the chemokine (C-X-C motif) ligand 7. Despite disparities in vitamin D status and the potential effects on disease attributes, significantly shortened cancer-specific survival was observed in vitamin D-deficient patients irrespective of sex. CONCLUSION: This unselected rectal cancer cohort confirmed the interconnection of low vitamin D, more advanced disease presentation, and poor survival, and further suggested it may be conditional on disparate modes of adverse systemic inflammation in men and women. TRIAL REGISTRATION: ClinicalTrials.govNCT01816607; registration date: 22 March 2013. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08260-2. BioMed Central 2021-05-11 /pmc/articles/PMC8111928/ /pubmed/33975557 http://dx.doi.org/10.1186/s12885-021-08260-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Abrahamsson, Hanna Meltzer, Sebastian Hagen, Vidar Nyløkken Johansen, Christin Bousquet, Paula A. Redalen, Kathrine Røe Ree, Anne Hansen Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer |
title | Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer |
title_full | Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer |
title_fullStr | Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer |
title_full_unstemmed | Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer |
title_short | Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer |
title_sort | sex disparities in vitamin d status and the impact on systemic inflammation and survival in rectal cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111928/ https://www.ncbi.nlm.nih.gov/pubmed/33975557 http://dx.doi.org/10.1186/s12885-021-08260-2 |
work_keys_str_mv | AT abrahamssonhanna sexdisparitiesinvitamindstatusandtheimpactonsystemicinflammationandsurvivalinrectalcancer AT meltzersebastian sexdisparitiesinvitamindstatusandtheimpactonsystemicinflammationandsurvivalinrectalcancer AT hagenvidarnyløkken sexdisparitiesinvitamindstatusandtheimpactonsystemicinflammationandsurvivalinrectalcancer AT johansenchristin sexdisparitiesinvitamindstatusandtheimpactonsystemicinflammationandsurvivalinrectalcancer AT bousquetpaulaa sexdisparitiesinvitamindstatusandtheimpactonsystemicinflammationandsurvivalinrectalcancer AT redalenkathrinerøe sexdisparitiesinvitamindstatusandtheimpactonsystemicinflammationandsurvivalinrectalcancer AT reeannehansen sexdisparitiesinvitamindstatusandtheimpactonsystemicinflammationandsurvivalinrectalcancer |